Monitor integration progress of Kineta acquisition and upcoming clinical trial developments, as the combined entity continues to operate at a significant loss despite executive compensation increases.
Price Chart
Executive Summary
TuHURA Biosciences completed its acquisition of Kineta and released updated pro forma financials showing a combined net loss of $34.6 million for 2025. The company also approved 2025 bonuses and 5% salary increases for its CEO and CFO.
Key Facts
- Completed acquisition of Kineta on June 30, 2025, with TuHURA as accounting acquirer
- Pro forma net loss attributable to common stockholders for 2025 was $34.6 million
- Weighted average shares outstanding increased to 54.3 million post-merger
- CEO James Bianco received $490,536 bonus and 5% salary increase to $605,956
- CFO Dan Dearborn received $163,393 bonus and 5% salary increase to $403,676
Financial Impact
Pro forma net loss of $34.6 million for 2025 with 54.3 million weighted average shares outstanding
Risk Factors
- Continued significant net losses post-acquisition
- Dilution from increased share count and warrant issuances
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-147660 |
| Document: d131347d8k.htm | 0001193125-26-147660 |
| Document: 0001193125-26-147660-index-headers.html | 0001193125-26-147660 |
| Document: 0001193125-26-147660-index.html | 0001193125-26-147660 |
| Document: 0001193125-26-147660.txt | 0001193125-26-147660 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.04 (+14.61%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.04 (−2.86%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.04 (−2.86%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.04 (−2.39%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.04 (−3.77%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.04 (−8.11%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.04 (−17.41%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.04 (−17.41%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.04 (−17.41%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.04 (−5.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers